Cognoptix
Marlborough
About Cognoptix
Cognoptix is creating and developing an innovative, non-invasive eye test to assist in the early diagnosis of Alzheimer's Disease. Cognoptix's goal is to provide clinicians with a quick, predictive, reliable, inexpensive, and widely available test, enabling early diagnosis and treatment. The company was founded in 2001 and headquartered in Marlborough, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $46.3M
- Last round: Series Unknown (Sep 2020)
- Website: cognoptix.com
- Phone: 508-251-1546
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/cognoptix-72163 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.